Protecting Innovation’s Portfolio While Fielding Business Requests

April 29, 2021
Despite grand plans for disruptive innovation and headline-grabbing announcements, plenty of organizations manage to get in their own way when it comes to innovation. Many believe they have an impressive range of innovation activities, covering the gamut from incremental (H1) to adjacent (H2) to... Read More

Innovation metrics: why NPV and Product Vitality aren’t enough

March 10, 2021
When I speak with R&D and innovation leaders about their key metrics, two measures rise to the top: NPV (Net Present Value) and PVI (Product Vitality Index). These are the de facto standards for assessing innovation impact. Nothing else comes close. When pressed, the very same leaders express a... Read More

Most Companies Don’t Have an Innovation Strategy. Here’s Why.

December 15, 2020
A few years ago, I was involved in a two-day boardroom session at a respected company – let’s call them Acme Corporation. They’d asked for help with their innovation strategy. Read More

WEBINAR: How Innovation Problem-Solving Can Build Better Teams

June 08, 2020
WITH GUEST SPEAKER Michelle Cohen Director of Innovation at CME Group The CME Group’s innovation team follows best practices that should be familiar to many corporate innovators: driving structured, collaborative, and creative thinking that creates value for their customers and the business. Along... Read More

Why Companies Need Their Innovators Now More Than Ever

May 08, 2020
By now, it’s a well-established fact that the COVID-19 pandemic is disrupting every aspect of society, including business. Companies are suddenly faced with a fully remote workforce, shifting corporate priorities, disrupted supply chains, and, in some industries, layoffs and dramatic drops in... Read More

Type I vs Type II Innovation Programs

March 30, 2020
In my decade-plus years working with corporate innovation leaders, I’ve seen a variety of frameworks to explain what we mean by “innovation.” The most enduring of these has been McKinsey’s Three Horizons model – although there are plenty of others. These models – powerful though they are – have... Read More

5 Ways to Avoid Innovation Theater

February 03, 2020
Anyone reading the typical startup-world commentary about Innovation Theater might be tempted to make one of two assumptions. First, big companies are clueless about how to innovate. Second, they must be screwing up innovation on purpose – playing a cynical game just to convince outsiders... Read More

“Innovation Ops” had been an oxymoron. Now it’s a best practice.

September 18, 2019
Even just a few years ago, conventional wisdom held that “innovation” and “operations” didn’t belong in the same sentence. Performance targets ruin the creative impulse. Science needs space, time, and freedom to flourish. Innovation can never be bottled into an efficient, machine-like operation. Read More

Why the Corporate Antibodies are Innovation’s Best Friend

July 24, 2019
There’s a repeated conversation that happens among corporate leaders, whispered in the halls of conferences and passed among friends like a rite of passage: “Watch out for the corporate antibodies,” goes the refrain. “They’ll kill your innovations faster than anything else.” Read More

How Organizations Can Build Incubators

June 25, 2019
Open innovation has hit the insurance sector, and many of the established giants are feeling the pressure. With industry giants like Nationwide, State Farm, Allstate, and AXA forming internal incubators and innovation programs to deal with the challenge from upstart competitors, the importance of... Read More
1 2 3

BROWSE CATEGORIES

SIGN UP
FOR EMAIL UPDATES

LEARN WHAT WELLSPRING CAN DO FOR YOU

Let's Talk